Skip to main content

US ClosedU.S. Closed

COGT: Cogent Biosciences, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies.

52W Range

72ndpctl

Volume

0.80×avg

Market Cap

5.92BUSD

P/E Ratio

-15.0TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

Cogent Biosciences, Inc.

COGTNASDAQ Global Select·USD·Closed

Cogent Biosciences, Inc.

COGTNASDAQ·USD·Closed

$34.67

−6.52%

$34.67

−$2.42 (6.52%)

52W Range

72ndpctl

Volume

0.80×avg

Mkt Cap

5.92BUSD

P/E

-15.0TTM

Div Yield

–ann